Oryzon Genomics SA (ORYZF)
3.27
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Oryzon Genomics Cash and Short Term Investments (Annual) : 33.32M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 33.32M |
| December 31, 2024 | 5.818M |
| December 31, 2023 | 13.54M |
| December 31, 2022 | 22.75M |
| December 31, 2021 | 32.67M |
| December 31, 2020 | 48.46M |
| December 31, 2019 | 39.57M |
| Date | Value |
|---|---|
| December 31, 2018 | 39.23M |
| December 31, 2017 | 42.14M |
| December 31, 2016 | 23.23M |
| December 31, 2015 | 23.58M |
| December 31, 2014 | 4.398M |
| December 31, 2013 | 2.805M |
| December 31, 2012 | 3.035M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Pharma Mar SA | 196.40M |
| Grifols SA | 968.92M |
| ACADIA Pharmaceuticals, Inc. | 819.69M |
| Alkermes Plc | 1.319B |
| Alnylam Pharmaceuticals, Inc. | 2.908B |